Cleared Traditional

K033863 - OX-GEN FLEXIBLE O2 GENERATION SYSTEM, MODEL 6-OX-03

K033863 is an FDA 510(k) clearance for OX-GEN FLEXIBLE O2 GENERATION SYSTEM, manufactured by Ox-Gen, Inc.. The device is a Class 2 Anesthesiology device with product code CAW cleared through the Traditional 510(k) pathway after a 619-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2005
Decision
619d
Days
Class 2
Risk

K033863 is an FDA 510(k) clearance for the OX-GEN FLEXIBLE O2 GENERATION SYSTEM, MODEL 6-OX-03. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by Ox-Gen, Inc. (Boise, US). The FDA issued a Cleared decision on August 22, 2005 after a review of 619 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

FDA 510(k) Submission Details - K033863

510(k) Number K033863 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2003
Decision Date August 22, 2005
Days to Decision 619 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
479d slower than avg
Panel avg: 140d · This submission: 619d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAW Device Classification - Class 2, Special Controls

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 224
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K033863.
EMG CTA01-XXX SERIES PURO OXYGEN CONCENTRATOR
K043520 · Emg Technology Co., Ltd. · Oct 2005
LONGFEI LFY-I-5 OXYGEN CONCENTRATOR
K033405 · Zhejiang Longfei Industrial Co., Ltd. · Oct 2005
PATIENT VENTILATION OXYGEN CONCENTRATING SYSTEM, HIGH FLOW (PVOCS HF)
K051887 · Carleton Life Support Systems, Inc. · Sep 2005
MERITS HEALTH PRODUCTS OXYGEN CONCENTRATOR
K050430 · Merits Health Products Co., Ltd. · Aug 2005
HOME-AWAY SYSTEM, MODEL 1041
K042944 · In-X Corporation · Apr 2005
MILLENNIUM M10 OXYGEN CONCENTRATOR, MODEL M10600
K043006 · Respironics, Inc. · Feb 2005